Plain-English translation of NCT06628921 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →This trial is testing whether eptinezumab, a migraine medication given by IV infusion, can stop a migraine attack while it's happening. Some patients have reported that their migraines resolved during or shortly after receiving this medication, but researchers want to study this more carefully in a real-world setting to understand how well it works and how quickly the pain goes away.
Most migraine medications are designed to prevent attacks from happening in the first place, but this study wants to see if this medication can actually stop pain once a migraine is already underway—filling an important gap in how we treat active migraine attacks.
You likely qualify if…
You likely don't qualify if…
You will receive this medication through an IV infusion during an active migraine attack, and researchers will track whether and when your migraine pain improves. You'll need to keep detailed records of your migraines before and during the study, and you'll be part of another related study (the TACHIS study) that involves ongoing migraine monitoring. The study involves multiple medical centers, so you'll work with migraine specialists who can give you the treatment and collect information about how quickly it works.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy